Article Information
History
- June 6, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Agustín Ciapponi1,*,
- Ariel Bardach1,
- Agustina Mazzoni1,
- Tomás Alconada1,
- Steven Anderson2,
- Fernando J. Argento1,
- Jamile Ballivian1,
- Karin Bok3,
- Daniel Comandé1,
- Emily Erbelding4,
- Erin Goucher5,
- Beate Kampmann6,
- Ruth Karron7,
- Flor M. Munoz8,
- María Carolina Palermo1,
- Edward P. K. Parker9,
- Federico Rodriguez Cairoli1,
- María Victoria Santa1,
- Andy Stergachis10,
- Gerald Voss11,
- Xu Xiong5,
- Natalia Zamora1,
- Sabra Zaraa12,
- Mabel Berrueta1 and
- Pierre M. Buekens5
- 1Instituto de Efectividad Clinica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina
- 2US Food & Drug Administration
- 3National Institute of Allergy and Infectious Diseases; National Institutes of Health
- 4National Institute of Allergy and Infectious Diseases
- 5School of Public Health and Tropical Medicine, Tulane University, New Orleans, USA
- 6“The Vaccine Centre, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK; Vaccines & Immunity Theme, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, The Gambia”
- 7Bloomberg School of Public Health, Johns Hopkins University
- 8Baylor College of Medicine; Texas Children's Hospital
- 9The Vaccine Centre, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
- 10School of Pharmacy and School of Public Health, University of Washington, Seattle, WA USA
- 11TuBerculosis Vaccine Initiative (TBVI, Lelystad, The Netherlands)
- 12School of Pharmacy, University of Washington, Seattle, USA
- ↵*Corresponding author; email: aciapponi{at}iecs.org.ar
Posted June 06, 2021.
Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review
